SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'CTN'


List of Similar Pattern of Amino Acids


Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1BU5_A_RBFA301_1
(PROTEIN (FLAVODOXIN))
3ive NUCLEOTIDASE
(Escherichia
coli)
4 / 7 THR A 463
THR A 475
GLY A 471
ASP A 472
None
None
None
CTN  A 603 (-2.7A)
0.94A 1bu5A-3iveA:
undetectable
1bu5A-3iveA:
15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HO5_A_ADNA1604_1
(5'-NUCLEOTIDASE)
3ive NUCLEOTIDASE
(Escherichia
coli)
6 / 11 GLY A 372
ARG A 375
PHE A 394
ASN A 396
PHE A 466
ASP A 472
CTN  A 603 (-3.2A)
CTN  A 603 ( 3.0A)
CTN  A 603 (-3.5A)
CTN  A 603 (-3.0A)
CTN  A 603 (-3.8A)
CTN  A 603 (-2.7A)
0.65A 1ho5A-3iveA:
37.3
1ho5A-3iveA:
28.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HO5_B_ADNB2604_1
(5'-NUCLEOTIDASE)
3ive NUCLEOTIDASE
(Escherichia
coli)
6 / 10 GLY A 372
ARG A 375
PHE A 394
ASN A 396
PHE A 466
ASP A 472
CTN  A 603 (-3.2A)
CTN  A 603 ( 3.0A)
CTN  A 603 (-3.5A)
CTN  A 603 (-3.0A)
CTN  A 603 (-3.8A)
CTN  A 603 (-2.7A)
0.51A 1ho5B-3iveA:
37.3
1ho5B-3iveA:
28.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OE1_A_CUA502_0
(DISSIMILATORY
COPPER-CONTAINING
NITRITE REDUCTASE)
3ive NUCLEOTIDASE
(Escherichia
coli)
3 / 3 ASP A  79
HIS A 112
HIS A  34
FE  A 602 (-2.6A)
CTN  A 603 ( 3.8A)
MN  A 601 ( 3.4A)
0.68A 1oe1A-3iveA:
undetectable
1oe1A-3iveA:
22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OE3_A_CUA502_0
(DISSIMILATORY
COPPER-CONTAINING
NITRITE REDUCTASE)
3ive NUCLEOTIDASE
(Escherichia
coli)
3 / 3 ASP A  79
HIS A 112
HIS A  34
FE  A 602 (-2.6A)
CTN  A 603 ( 3.8A)
MN  A 601 ( 3.4A)
0.67A 1oe3A-3iveA:
undetectable
1oe3A-3iveA:
22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RG9_A_SAMA385_1
(S-ADENOSYLMETHIONINE
SYNTHETASE)
4js1 BETA-GALACTOSIDE
ALPHA-2,6-SIALYLTRAN
SFERASE 1

(Homo
sapiens)
4 / 8 ALA A 190
GLU A 342
ASP A 339
ILE A 328
CTN  A 510 (-3.3A)
None
None
None
0.78A 1rg9B-4js1A:
undetectable
1rg9B-4js1A:
20.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ECP_A_ACRA992_1
(MALTODEXTRIN
PHOSPHORYLASE)
3ive NUCLEOTIDASE
(Escherichia
coli)
5 / 10 TYR A 342
ARG A 229
ASP A 472
ARG A 375
HIS A  34
None
None
CTN  A 603 (-2.7A)
CTN  A 603 ( 3.0A)
MN  A 601 ( 3.4A)
1.49A 2ecpA-3iveA:
undetectable
2ecpA-3iveA:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QBN_A_CAMA442_0
(CYTOCHROME P450-CAM)
3w34 URIDINE KINASE
(Thermus
thermophilus)
4 / 7 PHE A  65
TYR A  43
VAL A 165
VAL A 173
None
CTN  A 301 (-4.1A)
CTN  A 301 ( 4.8A)
None
0.98A 2qbnA-3w34A:
undetectable
2qbnA-3w34A:
20.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2RK8_A_PPFA3969_1
(PHOSPHOENOLPYRUVATE
CARBOXYKINASE,
CYTOSOLIC [GTP])
3ive NUCLEOTIDASE
(Escherichia
coli)
4 / 8 HIS A 116
SER A  87
ASP A 115
ALA A  35
None
None
CTN  A 603 ( 4.1A)
None
1.38A 2rk8A-3iveA:
undetectable
2rk8A-3iveA:
22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XXG_A_CUA1338_0
(DISSIMILATORY
COPPER-CONTAINING
NITRITE REDUCTASE)
3ive NUCLEOTIDASE
(Escherichia
coli)
3 / 3 ASP A  79
HIS A 112
HIS A  34
FE  A 602 (-2.6A)
CTN  A 603 ( 3.8A)
MN  A 601 ( 3.4A)
0.69A 2xxgA-3iveA:
undetectable
2xxgA-3iveA:
22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XXG_C_CUC1339_0
(DISSIMILATORY
COPPER-CONTAINING
NITRITE REDUCTASE)
3ive NUCLEOTIDASE
(Escherichia
coli)
3 / 3 ASP A  79
HIS A 112
HIS A  34
FE  A 602 (-2.6A)
CTN  A 603 ( 3.8A)
MN  A 601 ( 3.4A)
0.70A 2xxgC-3iveA:
undetectable
2xxgC-3iveA:
22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AOD_C_RFPC2002_1
(ACRIFLAVINE
RESISTANCE PROTEIN B)
3ive NUCLEOTIDASE
(Escherichia
coli)
5 / 12 ALA A 352
THR A 391
ASN A 370
GLY A 372
LEU A 467
None
None
CTN  A 603 (-3.2A)
CTN  A 603 (-3.2A)
None
1.44A 3aodC-3iveA:
undetectable
3aodC-3iveA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K13_A_THHA642_1
(5-METHYLTETRAHYDROFO
LATE-HOMOCYSTEINE
METHYLTRANSFERASE)
3ive NUCLEOTIDASE
(Escherichia
coli)
3 / 3 ASN A 396
ASP A 115
ARG A 229
CTN  A 603 (-3.0A)
CTN  A 603 ( 4.1A)
None
0.60A 3k13A-3iveA:
undetectable
3k13A-3iveA:
21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K13_C_THHC643_1
(5-METHYLTETRAHYDROFO
LATE-HOMOCYSTEINE
METHYLTRANSFERASE)
3ive NUCLEOTIDASE
(Escherichia
coli)
3 / 3 ASN A 396
ASP A 115
ARG A 229
CTN  A 603 (-3.0A)
CTN  A 603 ( 4.1A)
None
0.85A 3k13C-3iveA:
undetectable
3k13C-3iveA:
21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N62_A_MTLA870_0
(NITRIC OXIDE
SYNTHASE)
3ive NUCLEOTIDASE
(Escherichia
coli)
4 / 8 SER A 177
ASN A 396
PHE A 466
ASP A 469
CTN  A 603 (-4.2A)
CTN  A 603 (-3.0A)
CTN  A 603 (-3.8A)
None
1.23A 3n62A-3iveA:
undetectable
3n62A-3iveA:
21.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VNS_A_DVAA602_0
(NRPS ADENYLATION
PROTEIN CYTC1)
3ive NUCLEOTIDASE
(Escherichia
coli)
4 / 7 ASP A 115
PHE A 114
GLY A 110
THR A  82
CTN  A 603 ( 4.1A)
None
None
None
1.13A 3vnsA-3iveA:
undetectable
3vnsA-3iveA:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZTV_A_ADNA1600_1
(NAD NUCLEOTIDASE)
3ive NUCLEOTIDASE
(Escherichia
coli)
6 / 9 ASN A 370
GLY A 372
GLY A 373
PHE A 394
ASN A 396
ASP A 472
CTN  A 603 (-3.2A)
CTN  A 603 (-3.2A)
CTN  A 603 (-3.3A)
CTN  A 603 (-3.5A)
CTN  A 603 (-3.0A)
CTN  A 603 (-2.7A)
0.61A 3ztvA-3iveA:
33.3
3ztvA-3iveA:
28.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A81_A_DXCA1161_0
(MAJOR POLLEN
ALLERGEN BET V 1-A)
3ive NUCLEOTIDASE
(Escherichia
coli)
5 / 12 ILE A 109
GLY A  78
ASP A  79
ASP A 115
ASN A 120
None
None
FE  A 602 (-2.6A)
CTN  A 603 ( 4.1A)
None
0.92A 4a81A-3iveA:
undetectable
4a81A-3iveA:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FU8_A_ACTA302_0
(UROKINASE-TYPE
PLASMINOGEN
ACTIVATOR)
3ive NUCLEOTIDASE
(Escherichia
coli)
4 / 5 HIS A 112
TYR A 342
GLN A 219
GLY A 372
CTN  A 603 ( 3.8A)
None
None
CTN  A 603 (-3.2A)
1.28A 4fu8A-3iveA:
undetectable
4fu8A-3iveA:
18.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4H2F_A_ADNA601_1
(5'-NUCLEOTIDASE)
3ive NUCLEOTIDASE
(Escherichia
coli)
7 / 9 ASN A 370
GLY A 372
GLY A 373
ARG A 375
PHE A 394
PHE A 466
ASP A 472
CTN  A 603 (-3.2A)
CTN  A 603 (-3.2A)
CTN  A 603 (-3.3A)
CTN  A 603 ( 3.0A)
CTN  A 603 (-3.5A)
CTN  A 603 (-3.8A)
CTN  A 603 (-2.7A)
0.39A 4h2fA-3iveA:
35.0
4h2fA-3iveA:
28.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4H2G_A_ADNA603_1
(5'-NUCLEOTIDASE)
3ive NUCLEOTIDASE
(Escherichia
coli)
7 / 9 ASN A 370
GLY A 372
GLY A 373
ARG A 375
PHE A 394
PHE A 466
ASP A 472
CTN  A 603 (-3.2A)
CTN  A 603 (-3.2A)
CTN  A 603 (-3.3A)
CTN  A 603 ( 3.0A)
CTN  A 603 (-3.5A)
CTN  A 603 (-3.8A)
CTN  A 603 (-2.7A)
0.54A 4h2gA-3iveA:
34.8
4h2gA-3iveA:
28.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KTT_A_SAMA405_1
(S-ADENOSYLMETHIONINE
SYNTHASE ISOFORM
TYPE-2)
4js1 BETA-GALACTOSIDE
ALPHA-2,6-SIALYLTRAN
SFERASE 1

(Homo
sapiens)
4 / 8 ALA A 190
GLU A 342
ASP A 339
ILE A 328
CTN  A 510 (-3.3A)
None
None
None
0.77A 4kttB-4js1A:
undetectable
4kttB-4js1A:
20.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KTT_C_SAMC404_1
(S-ADENOSYLMETHIONINE
SYNTHASE ISOFORM
TYPE-2)
4js1 BETA-GALACTOSIDE
ALPHA-2,6-SIALYLTRAN
SFERASE 1

(Homo
sapiens)
4 / 8 ALA A 190
GLU A 342
ASP A 339
ILE A 328
CTN  A 510 (-3.3A)
None
None
None
0.82A 4kttD-4js1A:
undetectable
4kttD-4js1A:
20.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4N09_B_ADNB401_1
(ADENOSINE KINASE)
3ive NUCLEOTIDASE
(Escherichia
coli)
5 / 12 GLY A 373
GLY A 372
ASN A 370
ALA A 217
GLY A 471
CTN  A 603 (-3.3A)
CTN  A 603 (-3.2A)
CTN  A 603 (-3.2A)
SO4  A 604 (-3.7A)
None
1.02A 4n09B-3iveA:
undetectable
4n09B-3iveA:
21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4N09_B_ADNB401_1
(ADENOSINE KINASE)
3ive NUCLEOTIDASE
(Escherichia
coli)
5 / 12 GLY A 373
GLY A 372
ASN A 370
GLY A 471
ASP A 472
CTN  A 603 (-3.3A)
CTN  A 603 (-3.2A)
CTN  A 603 (-3.2A)
None
CTN  A 603 (-2.7A)
0.98A 4n09B-3iveA:
undetectable
4n09B-3iveA:
21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4N09_D_ADND401_1
(ADENOSINE KINASE)
3ive NUCLEOTIDASE
(Escherichia
coli)
5 / 12 GLY A 373
GLY A 372
ASN A 370
GLY A 471
ASP A 472
CTN  A 603 (-3.3A)
CTN  A 603 (-3.2A)
CTN  A 603 (-3.2A)
None
CTN  A 603 (-2.7A)
0.98A 4n09D-3iveA:
undetectable
4n09D-3iveA:
21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEI_A_SHHA2004_1
(HDAC6 PROTEIN)
3ive NUCLEOTIDASE
(Escherichia
coli)
5 / 12 PRO A 395
SER A  87
HIS A  34
GLY A  83
HIS A 112
None
None
MN  A 601 ( 3.4A)
None
CTN  A 603 ( 3.8A)
1.35A 5eeiA-3iveA:
undetectable
5eeiA-3iveA:
20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEI_B_SHHB801_1
(HDAC6 PROTEIN)
3ive NUCLEOTIDASE
(Escherichia
coli)
5 / 12 PRO A 395
SER A  87
HIS A  34
GLY A  83
HIS A 112
None
None
MN  A 601 ( 3.4A)
None
CTN  A 603 ( 3.8A)
1.35A 5eeiB-3iveA:
undetectable
5eeiB-3iveA:
20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEX_I_TRPI101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)
3ive NUCLEOTIDASE
(Escherichia
coli)
5 / 11 ARG A 375
GLY A  92
HIS A 116
ALA A  35
ILE A  95
CTN  A 603 ( 3.0A)
None
None
None
None
1.21A 5eexI-3iveA:
undetectable
5eexJ-3iveA:
undetectable
5eexI-3iveA:
10.77
5eexJ-3iveA:
10.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEY_I_TRPI101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)
3ive NUCLEOTIDASE
(Escherichia
coli)
5 / 11 ARG A 375
GLY A  92
HIS A 116
ALA A  35
ILE A  95
CTN  A 603 ( 3.0A)
None
None
None
None
1.21A 5eeyI-3iveA:
undetectable
5eeyJ-3iveA:
undetectable
5eeyI-3iveA:
10.77
5eeyJ-3iveA:
10.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEZ_I_TRPI101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)
3ive NUCLEOTIDASE
(Escherichia
coli)
5 / 11 ARG A 375
GLY A  92
HIS A 116
ALA A  35
ILE A  95
CTN  A 603 ( 3.0A)
None
None
None
None
1.21A 5eezI-3iveA:
undetectable
5eezJ-3iveA:
undetectable
5eezI-3iveA:
10.77
5eezJ-3iveA:
10.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF0_I_TRPI101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)
3ive NUCLEOTIDASE
(Escherichia
coli)
5 / 11 ARG A 375
GLY A  92
HIS A 116
ALA A  35
ILE A  95
CTN  A 603 ( 3.0A)
None
None
None
None
1.21A 5ef0I-3iveA:
undetectable
5ef0J-3iveA:
undetectable
5ef0I-3iveA:
10.77
5ef0J-3iveA:
10.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF1_I_TRPI101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)
3ive NUCLEOTIDASE
(Escherichia
coli)
5 / 11 ARG A 375
GLY A  92
HIS A 116
ALA A  35
ILE A  95
CTN  A 603 ( 3.0A)
None
None
None
None
1.21A 5ef1I-3iveA:
undetectable
5ef1J-3iveA:
undetectable
5ef1I-3iveA:
10.77
5ef1J-3iveA:
10.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF2_I_TRPI101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)
3ive NUCLEOTIDASE
(Escherichia
coli)
5 / 11 ARG A 375
GLY A  92
HIS A 116
ALA A  35
ILE A  95
CTN  A 603 ( 3.0A)
None
None
None
None
1.21A 5ef2I-3iveA:
undetectable
5ef2J-3iveA:
undetectable
5ef2I-3iveA:
10.77
5ef2J-3iveA:
10.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EF3_I_TRPI101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)
3ive NUCLEOTIDASE
(Escherichia
coli)
5 / 11 ARG A 375
GLY A  92
HIS A 116
ALA A  35
ILE A  95
CTN  A 603 ( 3.0A)
None
None
None
None
1.21A 5ef3I-3iveA:
undetectable
5ef3J-3iveA:
undetectable
5ef3I-3iveA:
10.77
5ef3J-3iveA:
10.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FBN_B_SAMB401_0
(S-ADENOSYLMETHIONINE
SYNTHASE ISOFORM
TYPE-2)
4js1 BETA-GALACTOSIDE
ALPHA-2,6-SIALYLTRAN
SFERASE 1

(Homo
sapiens)
4 / 7 ALA A 190
GLU A 342
ASP A 339
ILE A 328
CTN  A 510 (-3.3A)
None
None
None
0.80A 6fbnA-4js1A:
undetectable
6fbnA-4js1A:
20.64